Medical Aesthetics Market By Product (Aesthetic Lasers, Body Contouring and Skin Tightening  Devices, Aesthetic Implants, Breast Implants, Facial Implants, Other Implants), By Application (Surgical, Non-surgical), By End-user (Hospitals, Dermatology Centres, Clinics and Medical Spas, Beauty Centres, Others) and Geography

Medical Aesthetics Market size was valued at USD 10.42 billion in 2022 and is poised to grow at a significant CAGR of 11.2% from 2023-2029. Medical aesthetic devices are used for the treatment of impairments related to a person’s physical appearance, such as slackness of the skin, an excess of fat, cellulite, wrinkles, moles, scars, unwanted hair, skin discoloration, liver spots and spider veins. Both non-surgical and surgical procedures and combination of both are included in aesthetic medicine in order to intensify the appearance of patient. Appropriate replacement of missing/ dysfunctional part of the body due to congenital disorders, trauma and accidents are also possible with aesthetic implants. Factors which are propelling the growth of medical aesthetics market such as rise in adaptation of minimal invasive & non-invasive processes, increase in awareness about cosmetic procedures & rise in demand for the treatment of aesthetic among male patients, growing brand consciousness on cosmetic and beauty products increasing aging population pool, and availability of aesthetic devices which are user-friendly. However, cost of the treatment is being very high, low reimbursements and malfunctions risk concerned with implants, strict regulations on the aesthetics procedures, survival rate is low because of high potency of competitors in the market are the few factors that are hindering growth of medical aesthetics market. The most general use of the aesthetic lasers are to treat skin and hair that includes skin rejuvenation, tattoo removal and eliminate pigmented lesions. Due to the non-invasive features of the medical aesthetics, they procured high preference over the other devices among patients. Facial aesthetics are anticipated to report for the major share in medical aesthetics market due to the rising demand for facial the aesthetics and growing trends of non-invasive surgeries. Energy devices are anticipated to be as speedy growing segment of the market. Aesthetic practitioners have many choices of advanced instrumentations like flexible and soft needles, cannulas with blunt-tip and pen injectors for minimal invasive process.


Key Developments: 

In October 2016, Merz Aesthetics, received U.S.FDA approval for Cellfina System used for treatment of cellulite on thighs and buttocks of females.
In January, 2016, Allergan plc, received S.FDA approval for BOTOX (onabotulinumtoxinA) used to treat lower limb spasticity .
In December, 2015, Merz Aesthetics, received U.S. FDA approval for Xeomin (incobotulinumtoxinA) to treat upper limb spasticity (ULS)